Active Ingredient: TRICLABENDAZOLE
Proprietary Name: EGATEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208711
Product Number: 001
Approval Date: Feb 13, 2019
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
